Neither the maternal inheritance pattern nor the early onset of congenital myotonic dystrophy are fully explained. One possible mechanism is that mitochondrial DNA (mtDNA) mutations might interact with the DM gene product, producing an earlier onset than would otherwise occur. We have used Southern hybridisation to show that high levels of major rearrangements ofmtDNA are not present in muscle of five and in blood of 35 patients with congenital myotonic dystrophy. We used sequence analysis to show that no one particular mtDNA morph appears to cosegregate with congenital onset. A minor degree of depletion of mtDNA compared with nuclear DNA was present in the muscle of five patients with congenital DM, but we propose that this is not the primary cause of the muscle pathology but secondary to it. We have not found evidence that mtDNA is involved in congenital myotonic dystrophy. (J Med Genet 1995;32:732-735) 
Abstract
Neither the maternal inheritance pattern nor the early onset of congenital myotonic dystrophy are fully explained. One possible mechanism is that mitochondrial DNA (mtDNA) mutations might interact with the DM gene product, producing an earlier onset than would otherwise occur. We have used Southern hybridisation to show that high levels of major rearrangements ofmtDNA are not present in muscle of five and in blood of 35 patients with congenital myotonic dystrophy. We used sequence analysis to show that no one particular mtDNA morph appears to cosegregate with congenital onset. A minor degree of depletion of mtDNA compared with nuclear DNA was present in the muscle of five patients with congenital DM, but we propose that this is not the primary cause of the muscle pathology but secondary to it. We have not found evidence that mtDNA is involved in congenital myotonic dystrophy. The DM gene (DMPK) has recently been characterised'3 and it is now well established that expansion of a CTG triplet repeat in the 3' untranslated region of the gene is present in patients manifesting the disease.4 However, both the means by which it causes the adult phenotype and the cause of the in utero onset of congenital myotonic dystrophy (CMyD) remain unexplained.
The expansion may be associated with altered expression of the protein kinase which is encoded by DMPK. There is a rough correlation between the length of the repeat and disease severity,5 but this relationship is not as clear as has been shown for FMR1 in fragile X syndrome.6 Some of the variability may be explained by mosaicism for the expansion: the mean length in peripheral blood leucocytes may not closely reflect that found in muscle.7 Although the length of the expansion in muscle may correlate with severity rather better, the data are limited because biopsy is not essential for diagnosis.
CMyD occurs in about 10% of cases and appears to be quite distinct from severe adult onset DM. As well as earlier onset, there are often phenotypic differences from the typical later onset DM, such as mental retardation and characteristic facial appearance. It is almost always maternally inherited, and is usually associated with large triplet expansions in the mother or child or both.8 However, there is considerable overlap in the length of the expansion in blood between cases with congenital and adult onset.5 Furthermore, the increase in length of the repeat between generations may be more marked with paternal transmission.9
Thus, the magnitude of the fetus's triplet expansion is not sufficient to explain either the maternal inheritance pattern or the earlier onset of CMyD on its own. A recent study suggests that patients with congenital onset may be distinguished from those with adult onset if both fetal and maternal expansion sizes are taken into account.5 Congenital onset is more likely if both maternal and fetal expansions are large or if either one is very large. This suggests that there may be a determining factor produced by both mother and fetus whose level is influenced by the length of the expansion in both.
We have previously suggested that the ma- How might mtDNA interact with the DM gene to cause CMyD?27-29 Multiple interactions between nuclear and mitochondrial genes are known to occur during mitochondrial biogenesis since the majority of respiratory chain subunits are encoded in the nucleus, as are all of the components of their import pathway and enzymes required for their assembly. MtDNA polymorphisms are common, and variant mtDNAs might be neutral unless combined with a nuclear defect such as DM. However, in order to explain the observations, these mtDNA variants would need to cosegregate with the DM gene in order to interact in the embryo: if they were in equilibrium with the rest of the population, a fetus would receive the mtDNA variant as often from an unaffected as an affected mother. An interaction between these genes occurring during the development of the oocyte predicts a model of inheritance pattern very similar to any other maternal factor. 28 Four possible ways in which mtDNA abnormality and the DM gene might cosegregate were considered in this study. 
